The doctor-patient relationship in the generative AI era

Five reasons why the time to act for pharma is now.

Ipsos | Ipsos views | Healthcare | Generative AI Generative AI is revolutionizing the medical advice landscape, redefining the doctor-patient dynamic in ways previously unimaginable. This brings both huge opportunities and formidable challenges.

Drawing on new research among healthcare professionals, along with our vast experience in this field, we explore these potential impacts in detail.

We also consider the implications for pharmaceutical companies, providing five key reasons why the time for action is now.

We conclude with an incontestable truth: this is a high-risk, high-reward field and the companies that take the lead stand to reap the most significant benefits.

Download our paper

Download

Related news

  • Automotive Disruption and Trends Webinar
    Consumers Webinar

    Automotive Disruption and Trends Webinar

    Please join Ipsos and SAA for a discussion on the future of mobility based on insights from the 2025 Ipsos Navigator Study.
  • Obesity Week
    Public Health Event

    Obesity Week

    This is a conference that encompasses the full spectrum of obesity science: from basic science research, to translational research and clinical application, to public policy; from diet, exercise, lifestyle, and psychology to medical and surgical interventions; from pediatric to geriatric to underserved populations.
  • EPHMRA: Human Factors for Devices & Drugs
    Public Health Webinar

    EPHMRA: Human Factors for Devices & Drugs

    Ipsos is delighted to join EPHMRA for a 45-minute webinar discussion that will move beyond the basics to explore the application of HF research today.